Rein Therapeutics Inc (RNTX) earnings · $80.6M cap
These earnings events as JSON? API free 100/dayRein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
This RNTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RNTX revenue for 2025-12-31 was $0. Net income was -$49.9M. RNTX currently screens at market cap $80.6M.
When the next RNTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for RNTX. We will not invent a beat or miss.
Not investment advice. Full RNTX research stays on the stock page; the tape stays on the quote page.
RNTX earnings FAQ
What is RNTX's latest net income?
Latest cached Rein Therapeutics Inc (RNTX) net income was -$49.9M. Statements: https://lician.com/financials/rntx
What is RNTX's latest diluted EPS?
Latest cached Rein Therapeutics Inc (RNTX) diluted EPS for Dec 31, 2025 was -$1.96.
What period does the latest RNTX earnings print cover?
The latest cached Rein Therapeutics Inc (RNTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are RNTX earnings listed?
Cached earnings facts for Rein Therapeutics Inc (RNTX) are listed at https://lician.com/earnings/rntx. Statements: https://lician.com/financials/rntx
Not investment advice.